FORM OF OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT by and between ENDO PHARMACEUTICALS HOLDINGS INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of [ ], 2009Octreotide Contingent Cash Consideration Agreement • January 7th, 2009 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • Delaware
This OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT (this “Agreement”), dated as of [ ], 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, as Paying Agent (the “Paying Agent”).
